104 related articles for article (PubMed ID: 3680302)
21. Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase.
Dellepiane NI; Manghi MA; Eriksson PV; di Paola G; Cangelosi A
Zentralbl Bakteriol; 1992 Jun; 277(1):65-73. PubMed ID: 1520970
[TBL] [Abstract][Full Text] [Related]
22. Protection of mice inoculated with purified pertussis toxin and filamentous haemagglutinin against intracerebral challenge with live Bordetella pertussis.
Gupta RK; Saxena SN; Sharma SB; Ahuja S
Vaccine; 1990 Jun; 8(3):289. PubMed ID: 2363304
[No Abstract] [Full Text] [Related]
23. The effects of purified pertussis components and lipopolysaccharide on the results of the mouse weight gain test.
Gupta RK; Saxena SN; Sharma SB; Ahuja S
J Biol Stand; 1988 Oct; 16(4):321-31. PubMed ID: 3198661
[TBL] [Abstract][Full Text] [Related]
24. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.
Ryan EJ; Nilsson L; Kjellman N; Gothefors L; Mills KH
Clin Exp Immunol; 2000 Aug; 121(2):193-200. PubMed ID: 10931131
[TBL] [Abstract][Full Text] [Related]
25. Booster response to acellular pertussis vaccine in children primed with acellular or whole cell vaccines.
Edwards KM; Decker MD; Bradley RB; Taylor JC; Hager CC
Pediatr Infect Dis J; 1991 Apr; 10(4):315-8. PubMed ID: 2062628
[TBL] [Abstract][Full Text] [Related]
26. Effect of pertussis toxin on susceptibility of infant rats to Haemophilus influenzae type b.
Samore MH; Siber GR
J Infect Dis; 1992 May; 165(5):945-8. PubMed ID: 1533239
[TBL] [Abstract][Full Text] [Related]
27. Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.
Cropley I; Douce G; Roberts M; Chatfield S; Pizza M; Marsili I; Rappuoli R; Dougan G
Vaccine; 1995 Dec; 13(17):1643-8. PubMed ID: 8719514
[TBL] [Abstract][Full Text] [Related]
28. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
Vuolo AM; Lustigman B
Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
[TBL] [Abstract][Full Text] [Related]
29. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
30. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
[TBL] [Abstract][Full Text] [Related]
31. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule.
Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L
J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389
[TBL] [Abstract][Full Text] [Related]
32. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
33. Properties of the B oligomer of pertussis toxin.
Nencioni L; Pizza MG; Volpini G; De Magistris MT; Giovannoni F; Rappuoli R
Infect Immun; 1991 Dec; 59(12):4732-4. PubMed ID: 1937835
[TBL] [Abstract][Full Text] [Related]
34. Murine model for pertussis vaccine encephalopathy: linkage to H-2.
Steinman L; Sriram S; Adelman NE; Zamvil S; McDevitt HO; Urich H
Nature; 1982 Oct; 299(5885):738-40. PubMed ID: 7121603
[No Abstract] [Full Text] [Related]
35. Endotoxin-induced hypersensitivity to histamine in mice. I. Contrasting effects of bacterial lipopolysaccharides and the classical histamine-sensitizing factor of Bordetella pertussis.
Pieroni RE; Broderick EJ; Levine L
J Bacteriol; 1966 Jun; 91(6):2169-74. PubMed ID: 5943934
[TBL] [Abstract][Full Text] [Related]
36. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
Munoz JJ; Peacock MG
Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
[TBL] [Abstract][Full Text] [Related]
37. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
38. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
39. Expression of pertussis toxin correlates with pathogenesis in Bordetella species.
Monack D; Munoz JJ; Peacock MG; Black WJ; Falkow S
J Infect Dis; 1989 Feb; 159(2):205-10. PubMed ID: 2464653
[TBL] [Abstract][Full Text] [Related]
40. Detoxification of pertussis toxin by site-directed mutagenesis: a review of connaught strategy to develop a recombinant pertussis vaccine.
Loosmore S; Cockle S; Zealey G; Boux H; Phillips K; Fahim R; Klein M
Mol Immunol; 1991 Mar; 28(3):235-8. PubMed ID: 1708104
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
